The Conversation (0)
Tetra Bio-Pharma announced a set of new appointments to prepare for the start of their commercial activities.
Tetra Bio-Pharma (TSXV:TBP; OTCQB:TBPMF) announced a set of new appointments to prepare for the start of their commercial activities.
As quoted in the press release:
The appointments of Dr. Anne-Sophie Courtois to the position of Vice President, Marketing effective immediately and Mr. Bernard Lessard to the position of Chief Financial Officer (CFO), effective September 18, 2017. Mr. Lessard will be replacing Mr. Sabino Di Paola as CFO of the corporation.
“I am very proud and pleased to be able to count on Dr. Courtois and Mr. Lessard as members of our executive team,” said Bernard Fortier, CEO of Tetra Bio-Pharma. “They will be playing a key role as Tetra imminently initiates its commercial activities and generates revenues in 2017. These highly skilled and experienced individuals will further strengthen our organization as we execute our strategy and refine the tactics that will position Tetra as a biopharmaceutical leader in cannabinoid-based drug discovery, with a clinical program aimed at bringing novel drugs and treatments to patients and their healthcare providers.”
Click here to read the full press release.
Source: www.marketwired.com
